These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Prognostic value of symptoms during a normal or nonspecific electrocardiogram in emergency department patients with potential acute coronary syndrome. Chase M, Brown AM, Robey JL, Pollack CV, Shofer FS, Hollander JE. Acad Emerg Med; 2006 Oct; 13(10):1034-9. PubMed ID: 16973638 [Abstract] [Full Text] [Related]
25. Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18. Wylie JV, Murphy SA, Morrow DA, de Lemos JA, Antman EM, Cannon CP. Am Heart J; 2004 Jul; 148(1):173-80. PubMed ID: 15215808 [Abstract] [Full Text] [Related]
30. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Gehrie ER, Reynolds HR, Chen AY, Neelon BH, Roe MT, Gibler WB, Ohman EM, Newby LK, Peterson ED, Hochman JS. Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432 [Abstract] [Full Text] [Related]
32. Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute coronary syndromes. Bosch X, Théroux P. Am Heart J; 2005 Aug; 150(2):215-20. PubMed ID: 16086920 [Abstract] [Full Text] [Related]
33. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. Grabowski M, Filipiak KJ, Malek LA, Karpinski G, Huczek Z, Stolarz P, Spiewak M, Kochman J, Rudowski R, Opolski G. Int J Cardiol; 2007 Feb 14; 115(3):386-90. PubMed ID: 16860415 [Abstract] [Full Text] [Related]
34. Frequency and clinical correlates of changes in Thrombolysis In Myocardial Infarction risk score during observation period at emergency department in "low-risk" patients with acute chest pain. Pelliccia F, Salvini P, Cartoni D, Polletta B, Pasceri V, Pristipino C, Richichi G, Mercuro G, Tanzi P. Am J Cardiol; 2006 Mar 15; 97(6):781-4. PubMed ID: 16516575 [Abstract] [Full Text] [Related]
38. N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction. Khan SQ, Quinn P, Davies JE, Ng LL. Heart; 2008 Jan 15; 94(1):40-3. PubMed ID: 17488769 [Abstract] [Full Text] [Related]
39. Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 Registry. Yan AT, Yan RT, Huynh T, Casanova A, Raimondo FE, Fitchett DH, Langer A, Goodman SG, Canadian Acute Coronary Syndrome Registry 2 Investigators. Arch Intern Med; 2009 Feb 23; 169(4):372-8. PubMed ID: 19237721 [Abstract] [Full Text] [Related]
40. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Sabatine MS, Morrow DA, Giugliano RP, Murphy SA, Demopoulos LA, DiBattiste PM, Weintraub WS, McCabe CH, Antman EM, Cannon CP, Braunwald E. Circulation; 2004 Feb 24; 109(7):874-80. PubMed ID: 14757697 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]